ProteoMediX
ExitedIdentification of novel biomarkers for the early detection of cancer
ProteoMediX has raised €10M across 4 funding rounds from 1 investor, most recently a Series C round in Aug 2016. Based in Schlieren, Switzerland; founded 2010; active in Healthtech. Acquired by Blue Water Biotech in 2023. Data as of 28 Oct 2026.
Total raised
€10M
€10,200,000
Funding rounds
4
Investors
1
distinct backers
Active since
2012-01
latest 2016-08
Funding by year
EUR raised per yearProteoMediX — funding by year — interactive chart.
Data table
| ProteoMediX — funding by year | |
|---|---|
| 2011 | €2.1M |
| 2014 | €3.5M |
| 2016 | €4.6M |
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-08-01 | Series C | €4.6M | Altos Ventures | View deal → |
| 2015-01-01 | Series B | €900k | — | View deal → |
| 2014-04-01 | Series B | €2.6M | — | View deal → |
| 2012-01-01 | Series A | €2.1M | — | View deal → |
Exit
Type
acquisition
Date
Dec 2023
Value
—
Acquiror
Blue Water Biotech (United States of America)
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData